Compounds > azoxymethane
Page last updated: 2024-08-23

azoxymethane and ursodeoxycholic acid

azoxymethane has been researched along with ursodeoxycholic acid in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (41.67)18.2507
2000's7 (58.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bissonnette, M; Brasitus, TA; Earnest, DL; Frawley, BP; Hartmann, S; Khare, S; Roy, HK; Scaglione-Sewell, BA; Sitrin, MD; Wali, RK1
Bhattacharyya, AK; Bissonette, M; Brasitus, TA; Earnest, DL; Holubec, H; Jolley, CS; Khare, S; Roy, H; Wali, RK1
Alberts, D; Batta, AK; Brasitus, TA; Earnest, DL; Holubec, H; Salen, G1
Fukaura, Y; Narisawa, T; Sekiguchi, H; Terada, K1
Hirabayashi, N; Ikegami, T; Kano, M; Matsuzaki, Y; Shoda, J; Tanaka, N1
Lin, CX; Mimura, S; Monden, Y; Seraj, MJ; Umemoto, A1
Houchi, H; Momen, MA; Monden, Y; Umemoto, A1
Bissonnette, M; Brasitus, T; Hart, J; Nguyen, L; Sitrin, MD; Stoiber, D; Wali, RK1
Bissonnette, M; Brasitus, T; Cohen, G; Hart, J; Joseph, L; Khare, S; Nguyen, L; Ramaswamy, A; Sitrin, M; Tretiakova, M; Wali, RK; Wang, J; Wen, M1
Bissonnette, M; Boss, GR; Cerda, S; Cohen, G; Hart, J; Joseph, L; Khare, S; Nimmagadda, K; Sitrin, MD; Stoiber, D; Tretiakova, M; von Lintig, FC; Wali, RK1
Kohno, H; Miyamoto, S; Suzuki, R; Tanaka, T; Wakabayashi, K; Yasui, Y1
Bissonnette, M; Cerda, S; Cohen, G; Dougherty, U; Fichera, A; Holgren, C; Jagadeeswaran, S; Joseph, L; Khare, S; Li, YC; Moore, C; Mustafi, R; Samarel, A; Tretiakova, M; Wali, R; Wang, J; Yuan, W1

Other Studies

12 other study(ies) available for azoxymethane and ursodeoxycholic acid

ArticleYear
Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta.
    Cancer research, 1995, Nov-15, Volume: 55, Issue:22

    Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Cholic Acid; Cholic Acids; Colonic Neoplasms; Isoenzymes; Male; Protein Kinase C; Rats; Rats, Inbred F344; Ursodeoxycholic Acid

1995
Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid.
    Cancer research, 1994, Oct-01, Volume: 54, Issue:19

    Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Colonic Neoplasms; Diet; Male; Rats; Rats, Inbred F344; Ursodeoxycholic Acid

1994
Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps.
    Cancer research, 1998, Apr-15, Volume: 58, Issue:8

    Topics: Animals; Azoxymethane; Bile Acids and Salts; Cholic Acid; Cholic Acids; Colonic Polyps; Deoxycholic Acid; Feces; Lithocholic Acid; Male; Rats; Rats, Inbred F344; Retrospective Studies; Ursodeoxycholic Acid

1998
Prevention of N-methylnitrosourea-induced colon tumorigenesis by ursodeoxycholic acid in F344 rats.
    Japanese journal of cancer research : Gann, 1998, Volume: 89, Issue:10

    Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogens; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Methylnitrosourea; Rats; Rats, Inbred F344; Time Factors; Ursodeoxycholic Acid

1998
The chemopreventive role of ursodeoxycholic acid in azoxymethane-treated rats: suppressive effects on enhanced group II phospholipase A2 expression in colonic tissue.
    Cancer letters, 1998, Dec-25, Volume: 134, Issue:2

    Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogens; Colonic Neoplasms; DNA Primers; Gastrointestinal Agents; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Immunoblotting; Male; Phospholipases A; Phospholipases A2; Precancerous Conditions; Prostaglandins; Random Allocation; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Ursodeoxycholic Acid

1998
Effect of bile acids on formation of azoxymethane-induced aberrant crypt foci in colostomized F344 rat colon.
    Cancer letters, 2001, Aug-28, Volume: 169, Issue:2

    Topics: Animals; Apoptosis; Azoxymethane; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholic Acid; Colon; Deoxycholic Acid; Detergents; Diet; Dose-Response Relationship, Drug; Gastrointestinal Agents; Lithocholic Acid; Male; Mucous Membrane; Rats; Rats, Inbred F344; Ursodeoxycholic Acid

2001
Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+.
    The journal of medical investigation : JMI, 2002, Volume: 49, Issue:1-2

    Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Bile Acids and Salts; Calcium; Calcium Signaling; Carcinogens; Colon; Colonic Neoplasms; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Intracellular Fluid; Male; Rats; Rats, Inbred F344; Tumor Cells, Cultured; Ursodeoxycholic Acid

2002
Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2002, Volume: 11, Issue:11

    Topics: Animals; Azoxymethane; Cholagogues and Choleretics; Colonic Neoplasms; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Incidence; Male; Rats; Rats, Inbred F344; Time Factors; Treatment Outcome; Ursodeoxycholic Acid

2002
Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2002, Volume: 11, Issue:12

    Topics: Animals; Azoxymethane; Base Sequence; Biomarkers, Tumor; Biopsy, Needle; Blotting, Western; Cadherins; Cell Division; Cholecalciferol; Colonic Neoplasms; Cyclin D1; Disease Models, Animal; Immunohistochemistry; Injections, Intraperitoneal; Intestinal Mucosa; Male; Molecular Sequence Data; Neoplasms, Experimental; Polymerase Chain Reaction; Random Allocation; Rats; Rats, Inbred F344; Reference Values; RNA, Messenger; Sensitivity and Specificity; Ursodeoxycholic Acid

2002
Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer.
    Cancer research, 2003, Jul-01, Volume: 63, Issue:13

    Topics: Animals; Azoxymethane; Colonic Neoplasms; Cyclooxygenase 2; Gene Expression Regulation, Neoplastic; Genes, ras; Isoenzymes; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription, Genetic; Ursodeoxycholic Acid

2003
Ursodeoxycholic acid versus sulfasalazine in colitis-related colon carcinogenesis in mice.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Apr-15, Volume: 13, Issue:8

    Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Colitis; Colonic Neoplasms; Cyclooxygenase 2; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; RNA, Messenger; Sulfasalazine; Ursodeoxycholic Acid

2007
Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein.
    Nutrition and cancer, 2008, Volume: 60, Issue:3

    Topics: Animals; Azoxymethane; CCAAT-Enhancer-Binding Protein-beta; Cells, Cultured; Chemoprevention; Cholic Acid; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dietary Supplements; Gene Expression Regulation, Neoplastic; Genes, ras; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Transcription Factors; Transfection; Ursodeoxycholic Acid

2008